Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Amedisys Inc (NASDAQ: AMED) closed at $93.72 down -0.79% from its previous closing price of $94.47. In other words, the price has decreased by -$0.79 from its previous closing price. On the day, 0.6 million shares were traded.
Ratios:
For a deeper understanding of Amedisys Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.80 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.02. For the most recent quarter (mrq), Quick Ratio is recorded 1.29 and its Current Ratio is at 1.29. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.32.
Truist Downgraded its Buy to Hold on June 07, 2023, while the target price for the stock was maintained at $97.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 08 ’25 when Guidroz Allyson sold 374 shares for $96.00 per share. The transaction valued at 35,904 led to the insider holds 8,114 shares of the business.
Guidroz Allyson bought 374 shares of AMED for $35,853 on May 08 ’25. On Mar 04 ’25, another insider, Guidroz Allyson, who serves as the Chief Accounting Officer of the company, sold 2,041 shares for $92.03 each. As a result, the insider received 187,833 and left with 8,761 shares of the company.
Valuation Measures:
As of this moment, Amedisys’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.68, and their Forward P/E ratio for the next fiscal year is 18.05. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.30 while its Price-to-Book (P/B) ratio in mrq is 2.56.
Stock Price History:
Over the past 52 weeks, AMED has reached a high of $98.95, while it has fallen to a 52-week low of $82.15. The 50-Day Moving Average of the stock is 0.57%, while the 200-Day Moving Average is calculated to be 0.26%.
Shares Statistics:
A total of 32.82M shares are outstanding, with a floating share count of 31.92M. Insiders hold about 2.75% of the company’s shares, while institutions hold 86.14% stake in the company.
